ABOUT
TECHNOLOGY
Overview
Mechanism of Action
Pipeline
ADPKD
PATIENTS
INVESTORS
Overview
Press Releases
Events and Presentations
Financials & Filings
SEC Filings
Quarterly Results
Corporate Governance
Governance Documents
Board of Directors
Committee Composition
Analyst Coverage
Stock Information
Historical Stock Price
Investment Calculator
Insider Transactions
Fundamentals
Form 8937
Investor FAQs
Contact Us
CAREER
Toggle nav
Press Releases
.
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Investor Alerts
Year
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
October 02, 2015
Regulus to Present Updated Data Supporting RG-101 as Novel microRNA Therapeutic for the Treatment of HCV at The Liver Meeting® 2015 (AASLD)
-Phase I Clinical Data will be Featured in Viral Hepatitis Plenary Session-
Photos
1
August 25, 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Photos
1
August 06, 2015
Regulus to Present at the 2015 Wedbush PacGrow Healthcare Conference
Photos
1
August 04, 2015
Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights
-Advanced 'Clinical Map Initiative' with Start of Key Clinical Trials for RG-101 and RG-012-
Photos
1
July 28, 2015
Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call
Photos
1
Show
5
10
25
50
100
per page
«
1
…
39
40
41
42
43
44
45
…
64
»